VIEMED HEALTHCARE, INC. · Misc Health & Allied Services, NEC

VMD

Low riskNext report: In 7 days (est.)

View price ↗

The short version

A profitable company with growing sales. Institutions are adding.

Going well

Sales up 24% in the latest quarter vs a year ago
Profitable every year for 8 years
Sales up 21% last year

Money moves

No insider buying or selling in the last 30 days
Institutions added 9.2% to their holdings in the quarter ending June 2026 (100 bought, 44 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$9.74-0.5% that day

Company value: $371M; Share price times all shares
Price vs profit (P/E): 27.1x; You pay about $27 for each $1 of yearly profit
Price vs sales: 1.2x; Company value is 1.2 times a year of sales
Cash vs value: 3%; Cash as a share of company value
Debt vs value: 3%; Debt as a share of company value

From VMD's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$78.1M+24% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $301.6M, up 25% from the 12 months before. Over 5 years, sales grew about 16% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of VMD. Starting points are the company's recent numbers.

Sales growth+25% a yearRecently: +25% a yearProfit margin5%Last 12 months: 5.0%P/E at the end27xToday: 27.1x. Many steady companies trade at 12x to 25xShare count change+1% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$920M

Profit in 5 years$46M

Price these guesses point to$31.04+219% vs $9.74 todayAbout +26% a year, before dividends

What today's price needs: with a 5% margin and a 27x P/E, sales could shrink about 0.9% a year for 5 years and still match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

4/7Mixed

MissReturn on equity 15%+Earns a lot on the money owners have in the business.11.3%
PassDebt under half of equityNot relying on borrowed money.0.09x equity
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.5.7%
PassProfitable every yearSteady profits, not one good year.8 of 8 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$11.9M
MissShare count not growingNot diluting owners. Falling means buybacks.+2.6% in 3 years
PassGross margin 40%+Pricing power: sells for well above what it costs to make.57.5%

Revenue: $270.3M; +20.5% vs prior year
5-year growth: +15.5%/yr; revenue, per year
Total debt: $12.4M; 0.09x equity
Current ratio: 1.18x; short-term assets / bills due

From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.